Skip to content
200200200ZejulaZejulaZejula

Drawing based on the label description. No photo yet.

“ZEJULA 200-mg tablets are blue, debossed with "200" on one side and "Zejula" on the other side”

200 Zejula pill

Pill with imprint 200 Zejula is blue, oval, 16 mm and has been identified as Niraparib 200 mg. It is used for fallopian tube neoplasms, ovarian neoplasms and peritoneal neoplasms. It is supplied by Glaxosmithkline LLC.

Niraparib 200 mg

Imprint
200 Zejula
Strength
200 mg
Used for
Fallopian tube neoplasms, ovarian neoplasms and peritoneal neoplasms
Color
Blue
Shape
Oval
Size
16 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Glaxosmithkline LLC
Drug class
Poly(adp-ribose) polymerase inhibitor
NDC
0173-0912, 0173-0912-13, 0173-0912-61

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Niraparib pills and guides

What is Niraparib used for?

Niraparib is used for fallopian tube neoplasms, ovarian neoplasms and peritoneal neoplasms.

Medicine type
Poly(adp-ribose) polymerase inhibitor
Official uses from the US prescribing label

First-Line Maintenance Treatment of HRD-Positive Advanced Ovarian Cancer

ZEJULA is indicated for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD)-positive status defined by either:

  • a deleterious or suspected deleterious BRCA mutation, and/or
  • genomic instability.

Select patients for therapy based on an FDA‑authorized companion diagnostic for ZEJULA.

Maintenance Treatment of Recurrent Germline BRCA-Mutated Ovarian Cancer

ZEJULA is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAmut) recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.

Select patients for therapy based on an FDA‑authorized companion diagnostic for ZEJULA.

From the FDA-approved label on DailyMed (published Aug 06, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 200 and the other side shows Zejula.
  • It is blue, oval, 16 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Zejula.

Ingredients

Active: Niraparib Tosylate

Inactive: Crospovidone, Unspecified, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose, Povidone, Unspecified, Silicon Dioxide, Water

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Niraparib pills